News Briefs: August 5, 2019

FDA Warns CBD May Overpromise and Underdeliver

The FDA’s recent warning to CuraLeaf regarding unsubstantiated medical claims about CBD’s health benefits spotlights an ongoing issue about CBD products: Many claims about CBD-based treatments are unproven.

While CBD products have proliferated and experts agree there seems to be little direct risk to using CBD, consumers should know that the science still has a long way to go, according to Dr. Morton Tavel, a clinical professor emeritus of medicine at Indiana University School of Medicine.

Read More

 

Juul Launches ‘Smart’ E-Cigarette

Juul has just released a new e-cigarette which will monitor its user data, including when and where they vape, reports The Financial Times. In order to use the device, which is linked to an app on users’ smartphones, customers will have to go through stringent age verification and two-step background check with third-party databases. Juul’s C1 will also allow users to monitor how many puffs they take a day, as well as locate their vape if they lose it. It also has an auto-lock option that means the e-cigarette can be locked when out of the phone’s range in order to prevent others using it.

Read More

 

Cannabis Advertising Needs Educational Component

One of the biggest challenges for cannabis communication agencies is finding creative ways to advertise while at the same time educating the audience, whether it be the difference between THC and CBD, or where the plant is legal, or what investors need to consider when looking at cannabis. From a mass communications perspective, major players in cannabis are still largely uninformed, including physicians and consumers.

Read More

 

Colorado Doctors Allowed to Recommend Marijuana Instead of Opioids

A new law in Colorado allows doctors to prescribe patients medical marijuana instead of traditionally prescribed opiates for any condition as the state seeks to battle the opiate addiction crisis.

The law allows patients to choose medical marijuana as an alternative prescription for any diagnosis that would normally result in a prescription of an opioid-based medication.

Read More

 

Is Your Throat Sore? Vaping May Be to Blame

According to research published in the American Journal of Preventive Medicine, when people vape, a chemical reaction forms as a vanilla flavoring chemical called “vanillin” mixes with nicotine and glycerols to form acetals which can irritate the nose and throat. High or repeated exposure to acetal can cause headache, dizziness and drowsiness. While the chemical vanillin is used for vanilla flavoring in many e-cigarette flavorings, it is banned in tobacco cigarettes.

Read More

 

Emerging Regs for Cannabis Ads Include Prior Approval

As states legalize cannabis for medical and recreational use, some states, such as New York, Pennsylvania, and Nevada, require pre-approval by government agencies including the Department of Health. Billboard operators say prior approval has not caused problems; some managers appreciate the government sign-off.

One eventuallity may be self-regulation as has been adopted for liqour ads by the Distilled Spirits Council of the United States.

Read More

 

Texas Cops Told Not to Arrest in Low-Level Cannabis Cases

A memo obtained by The Texas Tribune instructs DPS officers to cite and release suspects in misdemeanor marijuana cases “as appropriate.” Officials said the goal is to continue enforcement even though some prosecutors aren’t taking new marijuana cases.

The difficulty arises from the fact that lab testing to differentiate between now-legal hemp and illegal marijuana is not currently available in government crime labs.

Read More

Recent Articles

Dr. Macias first fell in love with science while studying at Howard University, where she completed her undergraduate studies and later earned her PhD in cellular and molecular biology. While at Howard, she became especially interested in cancer research due to personal ties. Growing up in a Creole family and predominantly Black community in Louisiana, Dr. Macias watched many women around her battle breast cancer, so at Howard, she decided to focus her research on the BRCA1 gene.
It’s almost amazing that the same institutions that brought us the 2008 financial crisis have a problem with selling glass pipes. Almost. The truth is that an industry's past sins are only held against it when the money isn’t right. Big banks were willing to risk cratering the U.S. housing market because the profits were too good to ignore. But the cannabis industry rolls a different kind of paper, so instead of a slap on the wrist, it gets a surcharge.
Smokeshop and counterculture enthusiasts enjoy discovery as part of the experience. Customers enjoy browsing. When they walk into a shop, they don't simply grab a product and leave. They look for something new. This is the main reason flyers and posters still work. Smokeshops and dispensaries are highly visual environments. You want to see bold artwork, psychedelic graphics, and street-style posters that naturally capture attention.
The use of cannabis in professional sports has always been a controversial subject. While some are firm believers that all substances should be banned from professional sports altogether, most people aren’t thinking about cannabis when they’re discussing performance-enhancing drugs (PEDs). In fact, there have been countless cannabis users in the world of professional sports throughout the years; some of whom are more open about their love for the plant than others.
North Carolina might save us all. A new state bill may be the industry’s best option to save itself from demise when new federal cannabinoid bans take effect in November. And it could use your support.
Hemp is often considered for the things that it is not. It is not intoxicating, it is not illegal, and it is not marijuana. However, now we are seeing a focus back to what it can be. The plant is moving into the level of wine and chocolate and becoming a movement and a culture.
It’s been several months since President Donald Trump signed an executive order to reschedule cannabis from Schedule I to Schedule III within the Controlled Substances Act (CSA). On paper, the recent executive order, entitled “Increasing Medical Marijuana and Cannabidiol Research,” is a huge step in the right direction for cannabis smokers across the country.
For years, we’ve been told that this industry is the Wild West: a place where the only law amounts to whatever the guy with the gun says. But over the last 12 months, state governments have passed a spate of new regulations that promise to swap the relative lawlessness of poor enforcement of vague rules with real law and order.